Banco Bilbao Vizcaya Argentaria : Dividend Option Information

Market legislation, hereby communicates the following:

RELEVANT EVENT

BBVA hereby communicates information relating to the free-of-charge capital increase resolved by the Ordinary General Meeting of BBVA shareholders held on March 14,
2014, under agenda item fourth, section 4.1, by which a system of flexible shareholder remuneration called "Dividend Option" is to be instrumented. Accompanying this relevant event notice is an information document describing the free-of-charge capital increase for purposes of article 26.1.e) of Royal Decree 1310/2005, 4th November, partially developing Act 24/1988, 28th July, on Securities Exchange, with respect to the listing of securities for trading on regulated secondary markets, public bids of sale or subscription and the offering circular required for such purposes.
Madrid, March 26, 2014

THIS DOCUMENT HAS BEEN PREPARED IN ACCORDANCE WITH ARTICLE 26.1.E) OF ROYAL DECREE 1310/2005, 4th NOVEMBER, PARTIALLY DEVELOPING ACT 24/1988, 28TH JULY, ON SECURITIES EXCHANGE, WITH RESPECT TO THE LISTING OF SECURITIES FOR TRADING ON REGULATED SECONDARY MARKETS, PUBLIC BIDS OF SALE OR SUBSCRIPTION AND THE OFFERING CIRCULAR REQUIRED FOR SUCH PURPOSES.

The ordinary general shareholders' meeting of Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA" or the "Bank") held on March 14, 2014 resolved, under item 4.1 of the fourth point of its agenda, to increase the share capital of BBVA, to be charged against voluntary reserves, in accordance with the terms and conditions set out in the resolution (the "Capital Increase"), delegating the execution of the Capital Increase to the Board of Directors of BBVA pursuant to article 297.1.a) of Royal Legislative Decree 1/2010, of
2 July, by means of which the consolidated Spanish Capital Corporations Law was passed (the "Spanish Capital Corporations Law").
This information document (the "Information Document") has been issued in accordance with article 26.1.e) of Royal Decree 1310/2005, 4th November, partially developing Act 24/1988, 28th July, on Securities Exchange, with respect to the listing of securities for trading on regulated secondary markets, public bids of sale or subscription and the offering circular required for such purposes, which provides that the preparation and publication of a prospectus related to the admission to listing of the shares issued as a consequence of the execution of a free-of-charge capital increase will not be necessary provided that "a document is made available containing information on the number and nature of the shares and the reasons for and details of the offer". This
Information Document is available on the CNMV's website (www.cnmv.es) and on the
Bank's website (www.bbva.com).

The Capital Increase serves as an instrument for the implementation of the shareholder remuneration program named "Dividend Option", which offers BBVA shareholders the opportunity to elect to receive newly-issued BBVA shares or cash equivalent to the traditional complementary dividend.
The Dividend Option program is in line with other programs implemented by other domestic and international financial institutions and other major listed companies. With it, shareholders benefit from more flexibility and efficiency, since they will be able to adapt their remuneration to their preferences and personal situation.
The Dividend Option program works as follows:
When the execution of the Capital Increase is resolved, each shareholder will receive a right of free allocation for each BBVA share held at the record date. These rights will be listed and may be traded on the market during a fifteen calendar day period. Once this

period has elapsed, the rights will be automatically converted into newly-issued BBVA
shares.
Under the Dividend Option program, each shareholder may opt for one of the following alternatives:1
(i) Receive newly issued BBVA shares. In this case, the shareholder will receive free-of-charge the number of new shares corresponding to the number of rights held. The delivery of such shares will not be subject to Spanish withholding tax.
(ii) Receive their remuneration in cash. To this end, BBVA will assume an irrevocable undertaking to acquire the free allocation rights for a guaranteed fixed price during the first ten calendar days of the period during which the rights will be tradable, which is expected to take place from March 31, 2014 to April 9, 2014, both inclusive. This option is granted exclusively to the shareholders of BBVA who have such condition at the time the free allocation rights are assigned (which is expected to occur at 23:59 Madrid time on March 28, 2014) and only in connection with the free allocation rights which are originally assigned to them at such time; accordingly, this option will not be available in respect of any free allocation right acquired through a market purchase. This option will be subject to the same tax treatment applicable to dividends distributed directly in cash and, therefore, the amount to be paid to the shareholders will be subject to a 21% withholding tax.
(iii) Receive a cash payment through selling rights on the market. Given that the rights will be listed, shareholders may opt to sell them on the market at any time during the trading period described in section 3.4 below at the price at which the rights are trading at each moment rather than at the guaranteed fixe price offered by BBVA under the acquisition undertaking. The proceeds for the on the market sale will not be subject to withholding tax.
Additionally, shareholders will be able to combine the above mentioned alternatives in view of their preferences.
Shareholders who do not make an election will receive the number of new BBVA shares corresponding to them.

1 Special arrangements apply to BBVA shareholders who hold their shares in the form of ADSs. Please see section 5.

4

BBVA's Board of Directors, at its March 26, 2014 meeting, approved the execution of the Capital Increase on the terms approved by the Ordinary General Meeting of BBVA shareholders held on March 14, 2014, under item 4.1 of the fourth point of the agenda.
Pursuant to the formulas provided for in the resolution of the Ordinary General Meeting of BBVA shareholders, the Board of Directors of the Bank has established the terms of the Capital Increase as follows:
(i) The maximum number of new shares to be issued as a consequence of the execution of the Capital Increase (the "New Shares") will be

113,450,087. Accordingly, the maximum aggregate nominal value of the Capital Increase will be € 55,590,542.63, which is the product of multiplying the number of New Shares 113,450,087 by the nominal value of € 0.49 per New Share.

The maximum number of New Shares to be issued is the result of applying the formulas provided for in the applicable resolution adopted by the Ordinary General Meeting of BBVA shareholders, considering that the number of old shares outstanding is 5,785,954,443 ("NOS"), that the reference market value is € 1,000,000,000 ("RMV") and that the reference
price is € 8.710 ("reference price" or "RP").2 On this basis:
(a) The number of rights to be assigned ("rights to be assigned" or "NAR") is 51, in accordance with the formula indicated in the referred resolution (rounded up to the next whole number):
NAR = RP x NOS / RMV = 8.710 x 5,785,954,443 / 1,000,000,000 = 51 (b) The maximum number of New Shares to be issued is 113.450.087, in
accordance with the formula established by the Ordinary General
Meeting of BBVA shareholders (rounded down to the next whole number):

2 The Reference Price corresponds to the arithmetic mean of the average weighted price of BBVA shares traded on the Spanish SIBE electronic trading platform over the five trading days prior to March 26, 2014, the date that BBVA's Board of Directors resolved to effect the Capital Increase, rounded off to the nearest one-thousandth of a euro and, in the event of a half of one-thousandth of a euro, this will rounded up to the nearest one-thousandth.

5

New Shares = NOS / NAR = 5,785,954,443 / 51 = 113,450,087
Notwithstanding this, the number of New Shares actually issued and, as a result, the nominal value of the Capital Increase, may be less than the foregoing depending on the number of rights of free allocation acquired by the Bank pursuant to its undertaking to acquire the free allocation rights for a guaranteed fixed price. BBVA will waive the free allocation rights acquired pursuant to such undertaking. As a result, only those New Shares corresponding to the free allocation rights which have not been acquired by BBVA pursuant to its undertaking will be issued.
The New Shares will be issued at their nominal value of forty-nine euro cents (€ 0.49) per New Share, without issuance premium.
(ii) The number of rights (NAR) necessary to receive one New Share is 51.
BBVA shareholders who appear as such in the book-entry registries of Sociedad de Gestión de los Sistemas de Registro, Compensación y Liquidación de Valores, S.A. Unipersonal ("Iberclear") at 23:59 Madrid time on the day of publication of the announcement of the Capital Increase in the Official Bulletin of the Commercial Registry ("Boletín Oficial del Registro Mercantil") (envisaged for March 28, 2014) will receive a free allocation right for each BBVA share held at that time. Consequently, such shareholders will have a right to receive one New Share for each 51 shares held by them on such date.
To ensure that all free allocation rights are effectively exercisable and that the number of New Shares to be issued is a whole number, BBVA has renounced 6 rights corresponding to 6 shares held as treasury stock shares.

The fixed purchase price of each free allocation right assumed by BBVA is € 0.168 per right, in accordance with the formula included in point 6, section 4.1 of the shareholders' resolution adopted pursuant to agenda item 4 of the Ordinary General Meeting of BBVA shareholders held on March 14, 2014 (rounded off to the closest one-thousandth of a euro and, in the event of a half of a thousandth of a euro, by rounding up to the next whole thousandth):
Purchase price = RP / (NAR +1) = 8.710 / 51 + 1) = € 0.168

6

Accordingly, shareholders who wish to receive their remuneration in cash may sell their rights of free allocation to BBVA at a gross fixed price of € 0.168 per right.
BBVA's undertaking to acquire rights of free allocation at this fixed price will be in effect during the first ten calendar days of the period during which the rights will be tradable, which is expected to take place from March 31, 2014 to April 9, 2014, both inclusive.3

The expected calendar4 for the execution of the Capital Increase is the following:

• March 28, 2014 (23:59 Madrid time): Record date for allocation of rights.

• March 31, 2014: Rights trading period begins in Spain.

• April 9, 2014: Deadline for exercising the undertaking to acquire rights assumed by BBVA on the terms set forth above.

• April 14, 2014: Rights trading period ends.

• April 17, 2014: Date of payment to shareholders who have exercised the undertaking to acquire rights assumed by BBVA.

• April 24, 2014: New Shares allocated to shareholders.

• April 25, 2014: Initiation of ordinary trading of the New Shares on the Spanish stock exchanges5, subject to obtaining all necessary authorizations.

The free allocation rights will be assigned to the shareholders of BBVA who appear as such in the book-entry registries of Iberclear at 23:59 Madrid time on the day of publication of the announcement of the Capital Increase in the Official Bulletin of the Commercial Registry ("Boletín Oficial del Registro Mercantil") (envisaged for March 28,
2014). The trading period of the rights will begin on the next trading day and will have a

3 Special arrangements apply to BBVA shareholders who hold their shares in the form of ADSs. Please see section

5.

4 This schedule is tentative and may vary on the overseas exchanges where BBVA is traded. Please see section 5.

5 We will also seek admission to trading in foreign stock exchanges where BBVA is currently listed.

7

term of fifteen calendar days (envisaged from March 31 to April 14, 2014, both inclusive).
During the trading period of the rights, the shareholders may opt to receive cash or New Shares as explained above, as well as for acquiring in the market free allocation rights sufficient and in the necessary proportion to subscribe for New Shares.
However, those shareholders who wish to exercise the undertaking to acquire rights assumed by BBVA and receive cash at the fixed price will need to communicate their decision no later than the tenth calendar day of the period during which the right will be tradable, which is expected to take place on April 9, 2014. This option is granted exclusively to the shareholders of BBVA who have such condition at the time the free allocation rights are assigned (which is expected to occur at 23:59 Madrid time on March 28, 2014) and only in connection with the free allocation rights which are originally assigned to them at such time; accordingly, this option will not be available in respect of any free allocation right acquired through a market purchase.
In the absence of a timely express communication of such decision, shareholders will receive New Shares.
To choose among the alternatives offered by the "Dividend Option" program, shareholders will have to contact the entities where their BBVA shares and corresponding free allocation rights are deposited. Specifically:
(i) Shareholders whose shares are deposited at BBVA Group entities: Shareholders who wish to give instructions will have to give the relevant order. In the absence of an express communication, shareholders will receive New Shares and, if applicable, the proceeds of the liquidation in the market of any rights not- exercisable into a whole New Share.
BBVA shall not charge any fees or costs to those shareholders who opt to receive cash at the guaranteed fixed price or to receive New Shares. In case of sale of the rights on the market, BBVA shall charge the usual fees or costs pursuant to the applicable regulations.
(ii) Shareholders whose shares are deposited with other entities: These shareholders will have to contact the entity where their shares and rights are deposited to notify them their decision.
The depository entities may charge shareholders fees or costs related to the assignment of New Shares or the sale of rights pursuant to the applicable regulations.

8

The Capital Increase is carried out free of fees and costs for shareholders in connection with the assignment of the New Shares, with the Bank assuming the costs for the issue, subscription, placing on the market, admission to listing and other related costs.

The New Shares to be issued in the Capital Increase will be ordinary shares with a par value of € 0.49 each, of the same class and series and with the same rights as those currently outstanding.
The New Shares will be issued at an issue price of € 0.49, which is, without issuance premium, and will be represented in book-entry form, the records of which will be kept by Iberclear and its participant entities.

The Capital Increase is free of charge and, therefore, does not require any payment from the shareholders. The Capital Increase will be wholly charged against the freely distributable reserve named voluntary reserves, derived from retained earnings, which amounted to € 6,528,284,899.20 as of December 31, 2012.
The balance sheet used for purposes of the Capital Increase is that corresponding to December 31, 2013, duly audited by Deloitte, S.L. as of February 4, 2014 and approved by the Ordinary General Meeting of BBVA shareholder on March 14, 2014 under the first item of its agenda.

Following the end of the trading period of the free allocation rights, the New Shares that have not been capable of being assigned due to causes not attributable to BBVA will be kept in deposit and available to whomever evidences lawful ownership of the relevant free allocation rights.
Three years after the end of the free allocation rights trading period, the shares still pending to be allotted may be sold at the risk and expense of the interested parties in accordance with article 117 of the Spanish Capital Corporations Law. The net proceeds of the sale will be deposited in the Bank of Spain or in the General Deposit Bank (Caja General de Depósitos) at the disposal of the interested parties.

9

The New Shares will confer economic rights upon their holders from the date on which the New Shares are registered in the accounting records of Iberclear, and the right to participate in the distribution of the assets resulting from the liquidation of the Company.

The Bank will apply for the listing of the New Shares on the Madrid, Barcelona, Bilbao and Valencia Stock Exchanges through the Spanish SIBE electronic trading platform, and shall take the steps and actions that may be necessary with the competent bodies of the foreign stock exchanges on which BBVA shares are traded (currently London, Mexico and, through ADSs (American Depositary Shares), the New York Stock Exchange, as well as the Lima Stock Exchange, by virtue of the agreement among such exchanges) in order for the New Shares issued under the Capital Increase to be admitted to trading. Subject to the granting of the relevant authorizations, it is expected that the ordinary trading of the New Shares on the Spanish stock exchanges will begin on April 25, 2014.

In general, and pursuant to the criteria stated by the Tax Department (Dirección General de Tributos) in response to several binding queries, the applicable tax regulations in Spain for shareholders are as follows:
For tax purposes, the vesting of the New Shares will be deemed to be the vesting of free-of-charge shares and, consequently, does not comprise income for the purpose of Spanish personal income tax ("IRPF"), for corporate income tax ("IS") or for non- residents income tax ("IRNR"), whether or not acting through a permanent establishment in Spain.
The acquisition value of New Shares received as a consequence of the Capital Increase and of the shares from which they originate will be the total cost divided by the corresponding number of shares, including both old and newly issued shares. The seniority of such free-of-charge shares will be the same as the shares from which they originate.
If shareholders sell their free allocation rights on the market, the amount obtained from the transfer of such rights will, in general, be subject to the following taxes:
• In the case of IRPF and IRNR and if the transaction is carried out without the mediation of a permanent establishment, the amount obtained from the transfer of

10

free allocation rights on the market will receive the same tax treatment as pre- emptive subscription rights. Consequently, for tax purposes, the amount obtained from the transfer of the free allocation rights is subtracted from the acquisition value of the shares from which these rights originate, in application of article 37.1.a) of Act 35/2006, 28th November, on Personal Income Tax (IRPF), which partially
amends the Acts on Corporate Income Tax (IS), non-Resident Income Tax (IRNR)
and Wealth Tax (IP).
Thus only if the amount obtained from the transfer exceeds the acquisition value of the shares from which they originate will the difference be considered a capital gain of the transferor in the tax period in which the transfer takes place.
• In the case of IS and IRNR, when the transaction is carried out through a permanent establishment in Spain, insofar as it completes a full trading cycle, tax will be payable in accordance with the applicable accounting rules.
If BBVA shareholders entitled to the free allocation rights decide to exercise the BBVA undertaking to acquire the rights for cash, the tax regulations applicable to the amount obtained in the transfer to the Bank of the free allocation rights received due to the shareholder's status as such, will be equivalent to the tax regulations applicable to dividends distributed directly in cash and therefore subject to the corresponding withholding tax, which currently stands at 21%.
The amount obtained from the transmission of the free allocation rights in exercise of the acquisition commitment may benefit from the exemption, capped at € 1,500 a year, established under the prevailing regulations on dividends.

The options, terms and procedures indicated in this Information Document may not be the same in respect of BBVA shares listed outside Spain, including in the form of BBVA ADSs. Shareholders holding such shares should consult the public announcements made and other documents published in the relevant jurisdictions.

P.p.
Erik Schotkamp

11

distributed by